Predicting type 1 diabetes

被引：35

作者：

Achenbach P. ^{[1
]}

Bonifacio E. ^{[1
]}

Ziegler A.-G. ^{[1
]}

机构：

[1] Diabetes Research Institute, Munich 80804, Koelner Platz I

来源：

Current Diabetes Reports | 2005年 / 5卷 / 2期

关键词：

Islet Autoantibody; Islet Autoimmunity; Diabetes Prevention Trial; Multiple Islet Autoantibody; Diabetes Antibody Standardization Program;

D O I：

10.1007/s11892-005-0035-y

中图分类号：

学科分类号：

摘要：

Predicting type 1 diabetes mellitus (T1DM) is a prerequisite for disease prevention. Prediction is currently performed on three levels, which include the genetic susceptibility for disease, the identification of preclinical T1DM by way of circulating islet autoantibodies, and the use of metabolic tests to stage preclinical disease into late or early prediabetes. Combinations of genetic markers such as HLA genotype, INS genotype, and if and how much family history of T1DM is present can stratify disease risk more than 1000-fold, and can be used for selection of first-degree relatives of patients with T1DM for primary intervention trials. Measurement of autoantibodies in genetically at-risk subjects identifies future cases of T1DM. Further stratification of diabetes risk in autoantibody-positive subjects can be made on the basis of autoantibody characteristics that correspond to the magnitude of the autoantibody response. Copyright © 2005 by Current Science Inc.

引用

页码：98 / 103

页数：5

共 50 条

[1]

Redondo M.J., Eisenbarth G.S., Genetic control of autoimmunity in type I diabetes and associated disorders, Diabetologia, 45, pp. 605-622, (2002)

[2]

Hermann R., Bartsocas C.S., Soltesz G., Et al., Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence, Diabetes Metab. Res. Rev., 20, pp. 322-329, (2004)

[3]

Buzzetti R., Galgani A., Petrone A., Et al., Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIAB-FIN study), Diabetes Metab. Res. Rev., 20, pp. 137-143, (2004)

[4]

Van der Auwera B.J., Schuit F.C., Weets I., Et al., Relative and absolute HLA-DQA1-DQB1 linked risk for developing type I diabetes before 40 years of age in the Belgian population: Implications for future prevention studies, Hum. Immunol., 63, pp. 40-50, (2002)

[5]

Lambert A.P., Gillespie K.M., Thomson G., Et al., Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: A population-based study in the United Kingdom, J. Clin. Endocrinol. Metab., 89, pp. 4037-4043, (2004)

[6]

Gillespie K.M., Gale E.A., Bingley P.J., High familial risk and genetic susceptibility in early onset childhood diabetes, Diabetes, 51, pp. 210-214, (2002)

[7]

Walter M., Albert E., Conrad M., Et al., IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of type 1 diabetes and associated autoimmunity, Diabetologia, 46, pp. 712-720, (2003)

[8]

Nejentsev S., Sjoroos M., Soukka T., Et al., Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: Selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci, Diabet. Med., 16, pp. 985-992, (1999)

[9]

Rewers M., Bugawan T.L., Norris J.M., Et al., Newborn screening for HLA markers associated with IDDM: Diabetes autoimmunity study in the young (DAISY), Diabetologia, 39, pp. 807-812, (1996)

[10]

Kupila A., Muona P., Simell T., Et al., Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort, Diabetologia, 44, pp. 290-297, (2001)

← 1 2 3 4 5 →